Pure akinesia

A kinematic analysis in a case responsive to rotigotine

Roberto Di Fabio, Mariano Serrao, Francesco Pierelli, Gaia Fragiotta, Giorgio Sandrini

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

A patient with pure akinesia is described. This rare gait disorder, poorly responsive to therapy, is characterized by gait impairment which may be associated with handwriting and speech difficulties, in the absence of further signs of extrapyramidal involvement. Here, we report the improvement in a patient suffering from pure akinesia after low doses of rotigotine, a non-ergolinic dopamine agonist, detailing the kinematic analysis before and after the treatment. After therapy, an improvement in all of the gait parameters, particularly gait speed, was observed with a trend toward normalization. Our case report suggests that rotigotine may be a therapeutic option in cases of pure akinesia.

Original languageEnglish
Pages (from-to)133-135
Number of pages3
JournalFunctional Neurology
Volume28
Issue number2
DOIs
Publication statusPublished - 2013

Fingerprint

Biomechanical Phenomena
Gait
Handwriting
Dopamine Agonists
Therapeutics
N 0437

Keywords

  • Kinematic
  • Pure akinesia
  • Rotigotine
  • Therapy

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)

Cite this

Pure akinesia : A kinematic analysis in a case responsive to rotigotine. / Di Fabio, Roberto; Serrao, Mariano; Pierelli, Francesco; Fragiotta, Gaia; Sandrini, Giorgio.

In: Functional Neurology, Vol. 28, No. 2, 2013, p. 133-135.

Research output: Contribution to journalArticle

Di Fabio, Roberto ; Serrao, Mariano ; Pierelli, Francesco ; Fragiotta, Gaia ; Sandrini, Giorgio. / Pure akinesia : A kinematic analysis in a case responsive to rotigotine. In: Functional Neurology. 2013 ; Vol. 28, No. 2. pp. 133-135.
@article{c314ae30000a42969d2ca8d5cab95571,
title = "Pure akinesia: A kinematic analysis in a case responsive to rotigotine",
abstract = "A patient with pure akinesia is described. This rare gait disorder, poorly responsive to therapy, is characterized by gait impairment which may be associated with handwriting and speech difficulties, in the absence of further signs of extrapyramidal involvement. Here, we report the improvement in a patient suffering from pure akinesia after low doses of rotigotine, a non-ergolinic dopamine agonist, detailing the kinematic analysis before and after the treatment. After therapy, an improvement in all of the gait parameters, particularly gait speed, was observed with a trend toward normalization. Our case report suggests that rotigotine may be a therapeutic option in cases of pure akinesia.",
keywords = "Kinematic, Pure akinesia, Rotigotine, Therapy",
author = "{Di Fabio}, Roberto and Mariano Serrao and Francesco Pierelli and Gaia Fragiotta and Giorgio Sandrini",
year = "2013",
doi = "10.11138/FNeur/2013.28.1.133",
language = "English",
volume = "28",
pages = "133--135",
journal = "Functional Neurology",
issn = "0393-5264",
publisher = "CIC Edizioni Internazionali s.r.l.",
number = "2",

}

TY - JOUR

T1 - Pure akinesia

T2 - A kinematic analysis in a case responsive to rotigotine

AU - Di Fabio, Roberto

AU - Serrao, Mariano

AU - Pierelli, Francesco

AU - Fragiotta, Gaia

AU - Sandrini, Giorgio

PY - 2013

Y1 - 2013

N2 - A patient with pure akinesia is described. This rare gait disorder, poorly responsive to therapy, is characterized by gait impairment which may be associated with handwriting and speech difficulties, in the absence of further signs of extrapyramidal involvement. Here, we report the improvement in a patient suffering from pure akinesia after low doses of rotigotine, a non-ergolinic dopamine agonist, detailing the kinematic analysis before and after the treatment. After therapy, an improvement in all of the gait parameters, particularly gait speed, was observed with a trend toward normalization. Our case report suggests that rotigotine may be a therapeutic option in cases of pure akinesia.

AB - A patient with pure akinesia is described. This rare gait disorder, poorly responsive to therapy, is characterized by gait impairment which may be associated with handwriting and speech difficulties, in the absence of further signs of extrapyramidal involvement. Here, we report the improvement in a patient suffering from pure akinesia after low doses of rotigotine, a non-ergolinic dopamine agonist, detailing the kinematic analysis before and after the treatment. After therapy, an improvement in all of the gait parameters, particularly gait speed, was observed with a trend toward normalization. Our case report suggests that rotigotine may be a therapeutic option in cases of pure akinesia.

KW - Kinematic

KW - Pure akinesia

KW - Rotigotine

KW - Therapy

UR - http://www.scopus.com/inward/record.url?scp=84885744170&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84885744170&partnerID=8YFLogxK

U2 - 10.11138/FNeur/2013.28.1.133

DO - 10.11138/FNeur/2013.28.1.133

M3 - Article

VL - 28

SP - 133

EP - 135

JO - Functional Neurology

JF - Functional Neurology

SN - 0393-5264

IS - 2

ER -